Quanterix Corporation

US Genomics, Inc.

Jeffrey D Randall

David R Walt

David C Duffy

Eugene Y Chan

Martin Fuchs

David M Rissin

David Wilson

Kaj Blennow

John Henrik Zetterberg

Evan Ferrell

Xiaojian (David) Zhao

Bijit Kundu

Jessica Kesty

Steven R Gullans

Jenny Ellen Rooke

Steve R Gullans

The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.

Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury

The present invention relates to systems and methods for detecting analyte molecules or particles in a fluid sample and in some cases, determining a measure of the concentration of the molecules or particles in the fluid sample. Methods of the present invention may comprise immobilizing a plurality of analyte molecules or particles to form a plurality of complexes, releasing at least a portion of some of the plurality of complexes, determining at least a portion of the plurality of complexes released, and determining a measure of the concentration of the analyte molecules or particles in a fluid sample.

Ultra-sensitive detection of molecules on single molecule arrays

The invention relates to methods for analyzing and characterizing single polymers such as nucleic acid molecules. In preferred embodiments, the single molecules are analyzed using single molecule detection and analysis systems.

Methods and apparati using single polymer analysis

Growing community of inventors

Canton, MA, United States of America

Jeffrey D Randall